Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma

Clinical Cancer Research

Volumn 11, Issue 2 I, 2005, Pages 656-663

  An, Changhyeok ^a   Choi, In Seon ^a   Yao, James C ^a   Worah, Samidha ^a   Xie, Keping ^a   Mansfield, Paul F ^a   Ajani, Jaffer A ^a   Rashid, Asif ^a   Hamilton, Stanley R ^a   Wu, Tsung Teh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CPG ISLAND; FEMALE; GASTRECTOMY; GENE; GENE LOCUS; HMLH1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MISMATCH REPAIR; P16 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CADHERINS; CARRIER PROTEINS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, P16; GENOMIC INSTABILITY; HUMANS; MALE; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; NEOPLASM STAGING; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PROGNOSIS; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 19944428803     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Nardone G. Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 2003;17:75-81.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
3. Latham KE. X chromosome imprinting and inactivation in the early mammalian embryo. Trends Genet 1996;12:134-8.
4. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:534-40.
5. Lee YY, Kang SH, Seo JY, et al. Alterations of P16 INK4A and P15 INK4B genes in gastric carcinomas. Cancer 1997;80:1889-96.
6. Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-5.
7. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
8. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999;59: 3730-40.
9. Ukei T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic carcinoma. Cancer Res 2000;60:1835-9.
10. Toyota M, Ahuja N, Suzuki H, et al. Aberrent methylation in gastric cancer associated with CpG island methylator phenotype. Cancer Res 1999;59:5438-42.
11. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001;61:2847-51.
12. Lee JH, Park SJ, Abraham SC, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004;23:4646-54.
13. Leung WK, Yu J, Ng EKW, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissue. Cancer 2001;91:2294-301.
14. Carvalio B, Printo M, Cimes L, et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinoma. Eur J Cancer 2003;39:1222-7.
15. Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H. Concerted promoter hypermethylation of hMLH1, P16 INK4A and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol 2003 May; 200:23-31.
16. Akiyama Y, Nakasaki H, Nihei Z, et al. Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers. JPN J Cancer Res 1996;87:595-601.
17. Roberta AUB, Andrew JGS. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer 2000;87:200-3.
18. Guo RH, Arai H, Kitayama Y, et al. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa. Pathol Int 2001;51:240-7.
19. dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes M. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathological implications and prognosis. Gastroenterology 1996;110:38-44.
20. Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 2002;15:632-40.
21. Wirtz HC, Muller W, Noguchi T, et al. Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 1998;4:1749-54.
22. Philp AJ, Phillips WA, Rockman SP, et al. Microsatellite instability in gastrointestinal tract tumors. Int J Surg Investig 2000;2:267-74.
23. Hayden JD, Cawkwell L, Quirke P, et al. Prognostic Significance of microsatellite instability in patients with gastric carcinoma. Eur J Cancer 1997;33:2342-6.
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-9.
25. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997;150:1547-52
26. Herman JG, Graff JR, Sanna M, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
27. Boland CR, Thibodeau SN, Hamilton SR, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
28. Eads CA, Lord RV, Kurumboor SK, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021-6.
29. Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001;61: 3410-8.
30. Lee S, Kim WH, Jung HY, Yang MH, Kang GH. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol 2002;161:1015-22.
31. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001;7:584-9.
32. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002;8:131-7.
33. Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002;8:514-9.
34. Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002;122:1376-87.
35. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterization of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 2002;51:797-802.
36. van Rijnsoever M, Elsaleh H, Joseph D, McCaul K, Iacopetta B. CpG island methylator phenotype is an independent predictor of survival benefit from 5- fluorouracil in stage III colorectal cancer. Clin Cancer Res 2003;9:2898-903.
37. Brock MV, Gou M, Akiyama Y, et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 2003;9:2912-9.
38. Vo QN, Geradts J, Boudreau DA, Bravo JC, Schneider BG. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables. Hum Pathol 2002;33:1200-4.
39. 6- methylguanine-DNA methylatransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 2001; 92:2760-8.
40. Wu T-T, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-94.
41. Oue N, Shigeishi H, Kuniyasu H, et al. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001;93:805-9.
42. Shibata D, Sato F, Mori Y, et al. Hypermethylation of HPP1 is associated with hMHM1 hypermethylation in gastric adenocarcinomas. Cancer Res 2002;62:5637-40.
43. ARF gene in gastric cancer. Int J Cancer 2000;87:654-8.
44. Wang Y, Shinmura K, Guo RJ, et al. Mutational analyses of multiple target genes in histologically heterogeneous gastric cancer with microsatellite instability. Jpn J Cancer Res 1998;89:1284-91.
45. Keller G, Rudelius M, Vogelsang H, et al. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. Am J Pathol 1998;152:1281-9.
46. Kim HS, Woo DK, Bae SI, Kim YI, Kim WH. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 2000;80:57-64.
47. Leung WK, Kim JJ, Kim JG, Graham DY, Sepulveda AR. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000;156:537-43.
48. Ottini L, Palli D, Falchetti M, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997;57:4523-9.
49. Sepulveda AR, Santos AC, Yamaoka Y, et al. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol 1999;94:3034-8.
50. Fleisher AS, Esteller M, Tamura G, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 2001;20:329-35.
51. Oliveria C, Seruca R, Seixas M, Sobrinho-Simoes M. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different target genes. A study of the TGFβRII, IGFIIR and BAX genes. Am J Pathol 1998;153: 1211-9.
52. Yamamoto H, Perez-Piteria J, Yoshida T, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999;116:1348-57.